Heron Therapeutics, Inc /de/ (HRTX) insider trading
Every open-market stock purchase and sale by Heron Therapeutics, Inc /de/ executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Rubric Capital Management LP (10% owner), $3.6M, 14 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $0.30 on Oct 22, 2026.
Recent HRTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 19, 2026 | Craig A Collard (CEO) | Sold (not open market) | $1.2K |
| Oct 19, 2026 | William P Forbes (C-suite exec) | Sold (not open market) | $397 |
| Oct 19, 2026 | Ira Duarte (CFO) | Sold (not open market) | $397 |
| Oct 19, 2026 | Craig A Collard (CEO) | Bought (not open market) | — |
| Oct 19, 2026 | William P Forbes (C-suite exec) | Bought (not open market) | — |
| Oct 19, 2026 | William P Forbes (C-suite exec) | Bought (not open market) | — |
| Oct 19, 2026 | Craig A Collard (CEO) | Bought (not open market) | — |
| Oct 19, 2026 | Ira Duarte (CFO) | Bought (not open market) | — |
| Oct 19, 2026 | Ira Duarte (CFO) | Bought (not open market) | — |
| Aug 6, 2026 | Mark Earl Hensley (COO) | Sold (not open market) | $4.4K |
| Aug 6, 2026 | Mark Earl Hensley (COO) | Bought (not open market) | — |
| Aug 6, 2026 | Mark Earl Hensley (COO) | Bought (not open market) | — |
| Jul 31, 2026 | Ira Duarte (CFO) | Sold (not open market) | $1.7K |
| Jul 31, 2026 | William P Forbes (C-suite exec) | Sold (not open market) | $1.7K |
| Jul 31, 2026 | Ira Duarte (CFO) | Bought (not open market) | — |
| Jul 31, 2026 | Mark Earl Hensley (COO) | Bought (not open market) | — |
| Jul 31, 2026 | Mark Earl Hensley (COO) | Bought (not open market) | — |
| Jul 31, 2026 | William P Forbes (C-suite exec) | Bought (not open market) | — |
| Jul 31, 2026 | William P Forbes (C-suite exec) | Bought (not open market) | — |
| Jul 31, 2026 | Ira Duarte (CFO) | Bought (not open market) | — |
| Jul 31, 2026 | Craig A Collard (CEO) | Bought (not open market) | — |
| Jul 31, 2026 | Craig A Collard (CEO) | Bought (not open market) | — |
| Jul 30, 2026 | Ira Duarte (CFO) | Sold (not open market) | $1.9K |
| Jul 30, 2026 | William P Forbes (C-suite exec) | Sold (not open market) | $1.7K |
| Jul 30, 2026 | William P Forbes (C-suite exec) | Bought (not open market) | — |
Who's trading HRTX
- Craig A Collard, CEO: other filings, last Oct 19, 2026
- Ira Duarte, CFO: other filings, last Oct 19, 2026
- William P Forbes, C-suite exec: other filings, last Oct 19, 2026
- Mark Earl Hensley, COO: other filings, last Aug 6, 2026
- Michael Kaseta, Insider: other filings, last Jan 30, 2026
- Adam Morgan, Director: other filings, last Jan 30, 2026
- Waage Christian, Insider: other filings, last Jan 30, 2026
- Thomas Cusack, Insider: other filings, last Jan 30, 2026
- Sharmila Dissanaike, Insider: other filings, last Jan 30, 2026
- Craig A Johnson, Insider: other filings, last Jan 30, 2026
Get free alerts when an insider at Heron Therapeutics, Inc /de/ files a new trade →